Corporate Support
Sitemap

Features

Customer Services

Events

Terms of Use

Singapore
Malaysia

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,949.0
-24.5 (-0.82%)

 

  • STI Straits Times Index
    2,949.0
    -24.5 (-0.82%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,577.8
    -3.8 (-0.24%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,980.2
    -1,094.0 (-3.64%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,509.1
    -76.0 (-2.12%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    -
    -
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,241.8
    -47.8 (-0.76%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,281.1M
  • Value: 2,309.6M
  • Rise: 109
  • Fall: 262
  • Unch: 403

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol

  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
CWX Global0.007+0.002
Thomson Medical0.119-
Oceanus^0.071-0.004
Jiutian Chemical0.089-0.006
SPH1.400+0.120
Secura0.102-0.001
YZJ Shipbldg SGD1.070+0.010
Sembcorp Marine0.153-0.002
Anchor Resources0.015-
ThaiBev0.735-

World Indices

World Indices
Name Last Change
Nasdaq 13,119.4 -478.5
HSI 28,980.2 -1094.0
HSCEI 11,247.2 -470.2
Jakarta 6,241.8 -47.9
Nikkei 225 0.0
SSE Comp 3,509.1 -76.0
Shanghai A 3,678.3 -79.7
Shanghai B 243.4 -2.6
KOSPI 3,012.9 -86.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help

  • Factsheet

  • Print

CASI PHARMACEUTICALS INC CASI PHARMACEUTICALS
Updated on 25 Feb 2021 (End of trading day)
Last (USD): 2.490 Change: -0.160 High: 2.660 Remarks: -
Change (%): -6.04 Low: 2.480
Open 2.660 Yesterday's Close 2.6500000000000004
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 356,641 Cumulative Value
 
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.37139 Trailing EPS (USD) e -0.37910 NAV (USD) b 0.7385
PE a - Trailing PE f - Price / NAV b 3.3717
Dividend (USD) d - Cash In Hand (USD) g 0.6018 Issued & Paid-up Shares c 123,944,000
Dividend Yield (%) d - Price / Cash In Hand g 4.138 Treasury Shares h 79,545
Market Cap (M) 308.621 Enterprise Value (M) 255.867
Piotroski F Score 0 Exchange Code CASI Par Value ( $ ) n.a.
52 Weeks Volatility (%) 75.83 Free Float (%) 58.6
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 12 Aug 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CASI PHARMACEUTICALS INC NASDAQ 308.621 - - 3.3717 -
Industry Biotechnology NASDAQ 2,995.520 1438.131 - 7.3616 0.594
Local Peer AMGEN INC NASDAQ 131,407.816 18.090 18.090 13.9662 2.817
Local Peer GILEAD SCIENCES INC NASDAQ 78,738.660 640.126 640.152 4.3213 4.332
Local Peer ILLUMINA INC NASDAQ 65,050.974 99.163 99.163 13.8583 -
Local Peer MODERNA INC NASDAQ 58,715.450 - - 21.2753 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 55,366.281 20.418 20.418 6.3736 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 48,551.137 13.820 13.820 4.4036 -
Local Peer BIOGEN INC NASDAQ 42,236.679 10.558 10.558 3.9472 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 33,779.645 55.982 55.982 2.8992 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 30,162.052 - - 7.0349 -
Local Peer SEAGEN INC NASDAQ 27,190.905 44.309 44.309 7.7953 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 26,753.973 - - 24.5933 -
Local Peer EXACT SCIENCES CORP NASDAQ 22,201.911 - - 7.8633 -
Other Local Peers 10X GENOMICS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), BIO-TECHNE CORP (NASDAQ), NOVAVAX INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), FIBROGEN INC (NASDAQ), VERACYTE INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), ARVINAS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), SEER INC (NASDAQ), ALKERMES PLC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VIELA BIO INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), XENCOR INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ALLOVIR INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), VOR BIOPHARMA INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), BIOATLA INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), SERES THERAPEUTICS (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), SHATTUCK LABS INC (NASDAQ), PRECIGEN INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), UNIQURE N.V. (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), NKARTA INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), IMMUNOVANT INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), OCUGEN INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), CYTOKINETICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), VAXCYTE INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), OMEROS CORP (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), VANDA PHARMACE INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), INHIBRX INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), CORTEXYME INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), PASSAGE BIO INC (NASDAQ), HUMANIGEN INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), PROTHENA CORP PLC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), CHIMERIX INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), VAXART INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), KADMON HLDGS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), AGENUS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), MERUS B V (NASDAQ), COMPUGEN (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), IMMATICS N V (NASDAQ), AKOUOS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ATRECA INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), ARDELYX INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), ALTIMMUNE INC (NASDAQ), GERON CORP (NASDAQ), XBIOTECH INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), IVERIC BIO INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), ADICET BIO INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), AVROBIO INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), ONCORUS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), SESEN BIO INC (NASDAQ), ATHERSYS INC (NASDAQ), IMMUNOME INC (NASDAQ), BIOVIE INC (NASDAQ), VERASTEM INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), XOMA CORP (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), TREVENA INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), NEXTCURE INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), KAMADA LTD (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), MEDICINOVA INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), IMV INC (NASDAQ), CHIASMA INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), EVOGENE LTD (NASDAQ), AXCELLA HEALTH INC (NASDAQ), EQUILLIUM INC (NASDAQ), METACRINE INC (NASDAQ), INMUNE BIO INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ORGENESIS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), CONTRAFECT CORP (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ARAVIVE INC (NASDAQ), LONGEVERON INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), SYNLOGIC INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), INFLARX N V (NASDAQ), RECRO PHARMA INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ADVAXIS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SAVARA INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), BIOCARDIA INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), SOLIGENIX INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), PRECIPIO INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), HISTOGEN INC (NASDAQ), GEOVAX LABS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), SENESTECH INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ)
Global Peer CSL LTD ASX 119,481.601 38.096 31.394 11.3063 1.118
Global Peer WUXI BIO HKEx 404,384.907 351.767 280.841 27.0708 -
Global Peer BEIGENE HKEx 225,347.715 - - 6.7819 -
Global Peer SINO BIOPHARM HKEx 162,363.379 52.899 63.447 4.5049 0.618
Global Peer ZAI LAB-SB HKEx 97,530.814 - - 27.0350 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 5,178.095 16.972 16.972 3.5785 -
Global Peer Lonza SGX 5,940.891 4.560 4.560 0.5844 5.624
Global Peer JOINN HKEx 37,367.612 198.936 876.777 38.4991 0.146
Global Peer GENSCRIPT BIO HKEx 26,117.512 - - 3.5721 -
Global Peer 3SBIO HKEx 19,636.592 17.785 13.078 1.6787 -
Other Global Peers NUVATION BIO INC (NYSE), ARCUS BIOSCIENCES INC (NYSE), JW THERAP-B (HKEx), JACOBIO-B (HKEx), MYOVANT SCIENCES LTD (NYSE), VIVA BIOTECH (HKEx), ALPHAMAB-B (HKEx), FRONTAGE (HKEx), HAOHAI BIOTEC (HKEx), POLYNOVO LIMITED (ASX), JHBP-B (HKEx), MESOBLAST LTD (ASX), ASCENTAGE-B (HKEx), TELIX PHARMACEUTIC (ASX), KINTOR PHARMA-B (HKEx), ACTINIUM PHARMACEUTICALS INC (NYSE American), SINOMAB BIO-B (HKEx), DPHARMA (Bursa), LEE'S PHARM (HKEx), ASCLETIS-B (HKEx), OPTHEA LIMITED (ASX), SQZ BIOTECHNOLOGIES CO (NYSE), IMUGENE LIMITED (ASX), ANTEOTECH LIMITED (ASX), 22ND CENTURY GROUP INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), ESSEX BIO-TECH (HKEx), NANOVIRICIDES INC (NYSE American), NEXT SCIENCE LTD (ASX), BIONOMICS LTD (ASX), IMMUTEP LTD (ASX), IBIO INC (NYSE American), CEL-SCI CORP (NYSE American), ENZO BIOCHEM INC (NYSE), KAZIA THERAPEUTICS LIMITED (ASX), NEUREN PHARMACEUTICALS LTD (ASX), PALATIN TECHNOLOGIES INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), UNI-BIO GROUP (HKEx), LEAF RESOURCES LTD (ASX), CHIMERIC THERAPEUTICS LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), REGENT PACIFIC (HKEx), GENETIC TECHNOLOGIES (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), MEMPHASYS LTD (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ORAGENICS INC (NYSE American), PRESCIENT THERAPEUTICS LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), CT ENTERPRISE (HKEx), PATRYS LIMITED (ASX), BIOTRON (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), AVECHO BIOTECHNOLOGY LTD (ASX), Suntar Eco-City (SGX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), ADALTA LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), RHINOMED LIMITED (ASX), REGENEUS LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), HOLISTA COLLTECH LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), NANOLLOSE LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), CRYOSITE (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.300
-10.75 %
10 Days --0.400
-13.84 %
20 Days --0.870
-25.89 %
Medium Term Return 3 Months -+0.070
+2.89 %
6 Months -+0.750
+43.10 %
1 Year -+0.720
+40.68 %
Long Term Return 2 Years --0.850
-25.45 %
3 Years --0.990
-28.45 %
5 Years -+1.537
+161.28 %
Annualised Return Annualised --
+21.18 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.150 - 3.900 Change From 1 Year Low +1.340 % Change From 1 Year Low (%) +116.52
Change From 1 Year High -1.410 % Change From 1 Year High (%) -36.15
2 Years Range 1.150 - 3.900 Change From 2 Years Low +1.340 % Change From 2 Years Low (%) +116.52
Change From 2 Years High -1.410 % Change From 2 Years High (%) -36.15
5 Years Range 0.785 - 8.892 Change From 5 Years Low +1.705 % Change From 5 Years Low (%) +217.20
Change From 5 Years High -6.402 % Change From 5 Years High (%) -72.00
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau. Its products include ZEVALIN, EVOMELA and MARQIBO. CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD.

Historical Price Data

Date Open High Low Close Volume VWAP
25 Feb 2021 2.660 2.660 2.480 2.490 356,641 -
24 Feb 2021 2.690 2.830 2.540 2.650 391,533 -
23 Feb 2021 2.700 2.700 2.460 2.540 547,963 -
22 Feb 2021 2.830 2.840 2.740 2.740 248,381 -
19 Feb 2021 2.790 2.920 2.750 2.790 363,075 -
18 Feb 2021 2.860 2.878 2.750 2.790 281,633 -
17 Feb 2021 2.860 2.940 2.770 2.880 439,103 -
16 Feb 2021 2.980 3.010 2.800 2.830 565,660 -
12 Feb 2021 3.030 3.030 2.730 2.890 1,189,365 -
11 Feb 2021 3.110 3.240 3.000 3.000 501,145 -
10 Feb 2021 3.360 3.400 3.010 3.200 629,988 -
09 Feb 2021 3.400 3.470 3.310 3.340 431,820 -
08 Feb 2021 3.500 3.520 3.300 3.400 749,647 -
05 Feb 2021 3.560 3.560 3.260 3.480 717,999 -
04 Feb 2021 3.420 3.550 3.390 3.540 304,483 -
03 Feb 2021 3.600 3.680 3.340 3.440 724,389 -
02 Feb 2021 3.490 3.500 3.390 3.480 175,415 -
01 Feb 2021 3.360 3.490 3.310 3.470 300,847 -
29 Jan 2021 3.430 3.490 3.230 3.360 542,474 -
28 Jan 2021 3.550 3.600 3.350 3.430 500,907 -
27 Jan 2021 3.610 3.700 3.386 3.560 616,524 -
26 Jan 2021 3.805 3.900 3.470 3.630 1,361,273 -
Summary
Current 2 Weeks
(11 Feb 2021 to 25 Feb 2021)		 3.110 3.240 2.460 2.490 4,884,499 -
Previous 2 Weeks
(28 Jan 2021 to 10 Feb 2021)		 3.550 3.600 2.460 3.200 5,077,969 -
4 Weeks from
(29 Dec 2020 to 27 Jan 2021)		 2.940 3.240 2.460 3.560 10,568,267 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.